FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Deborah Thomas

Research Profile

Concepts & Ideas

Procedures

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Partow Kebriaei; Susan O'Brien; Farhad Ravandi; Deborah Thomas; Kaci Wilhelm; Laura Worth; Mark Brandt; Richard E Champlin; Stefan Ciurea; Marcos De Lima; Hagop Kantarjian
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
Hagop Kantarjian; Deborah Thomas; ALAN WAYNE; Susan O'Brien
Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
Deborah Thomas
Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Deborah Thomas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Partow Kebriaei; Susan O'Brien; Farhad Ravandi; Deborah Thomas; Kaci Wilhelm; Laura Worth; Mark Brandt; Richard E Champlin; Stefan Ciurea; Marcos De Lima; Hagop Kantarjian
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicin.
Clinical lymphoma, myeloma & leukemia 2013;13(3):296-301.
2012: Hagop Kantarjian; Deborah Thomas; ALAN WAYNE; Susan O'Brien
Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(31):3876-83.
2012: Deborah Thomas
Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia.
The lancet oncology 2012;13(9):860-2.
2012: Olga Frolova; Rodrigo Jacamo; Hagop Kantarjian; Sergej Konoplev; Michael Andreeff; Juliana Maria Benito; Daniela Buglio; Steven M Kornblau; Richard Lock; Hongbo Lu; Ana Markovic; Teresa McQueen; Sherry Pierce; Yi Hua Qiu; Ismael Samudio; Wendy Schober; Elizabeth Shpall; Deborah Thomas; Marina Konopleva
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
Cancer biology & therapy 2012;13(10):858-70.
2012: Hagop Kantarjian; Partow Kebriaei; Monica Kwari; Anjali Advani; Richard Champlin; Jorge Cortes; Stefan Faderl; Luis Fayad; Elias Jabbour; Jeffrey Jorgensen; Farhad Ravandi; Mary Beth Rios; Michael Rytting; Robert Tarnai; Deborah Thomas; Sa A Wang; Sergernne York; Susan O'Brien
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.
The lancet oncology 2012;13(4):403-11.
2011: Elias Jabbour; Hagop Kantarjian; Sherry Pierce; Deborah Thomas; Jorge Cortes; Lingsha Zhou; Srdan Verstovsek
Comparison of thalidomide and lenalidomide as therapy for myelofibrosis.
Blood 2011;118(4):899-902.
2010: Hagop M Kantarjian; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Elias Jabbour; Guillermo Garcia-Manero; Sherry Pierce; Jianquin Shan; Jorge Cortes; Susan O'Brien
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration.
Cancer 2010;116(24):5568-74.
2010: Deborah Thomas; Susan O'Brien; Stefan Faderl; Farhad Ravandi; Elias Jabbour; Sherry Pierce; Jorge Cortes; Andrew Lamb
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.
Cancer 2010;116(19):4580-9.
2010: Effrosyni Apostolidou; Andrew Lamb; Deborah Thomas; Ian Burger; Gautam Borthakur; Srdan Verstovsek
Phase II study of sunitinib in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.
Clinical lymphoma, myeloma & leukemia 2010;10(4):281-4.
2010: Fabio P S Santos; Andrew Lamb; Carmen Fava; Susan O'Brien; Guillermo Garcia-Manero; Farhad Ravandi; William G Wierda; Deborah Thomas; Jianquin Shan; Jorge Cortes
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.
British journal of haematology 2010;150(3):303-12.
2010: Elias Jabbour; Deborah Thomas; Jorge Cortes; Hagop M Kantarjian; Susan O'Brien
Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.
Cancer 2010;116(10):2290-300.
2010: Farhad Ravandi; Jorge E Cortes; Daniel Jones; Stefan Faderl; Guillermo Garcia-Manero; Marina Konopleva; Susan O'Brien; Zeev Estrov; Gautam Borthakur; Deborah Thomas; Sherry R Pierce; Mark Brandt; Anna Byrd; B Nebiyou Bekele; Keith William Pratz; Rajyalakshmi Luthra; Mark Levis; Michael Andreeff; Hagop M Kantarjian
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1856-62.
2010: Hagop M Kantarjian; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Guillermo Garcia-Manero; Jianquin Shan; Sherry Pierce; Jorge Cortes; Susan O'Brien
Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remission.
Leukemia & lymphoma 2010;51(3):475-80.
2009: Alfonso Quintás-Cardama; Hagop M Kantarjian; Taghi Manshouri; Deborah Thomas; Jorge Cortes; Farhad Ravandi; Guillermo Garcia-Manero; Alessandra Ferrajoli; Carlos E Bueso-Ramos; Srdan Verstovsek
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4760-6.
2009: Alfonso Quintás-Cardama; Andrew Lamb; Farhad Ravandi; Susan O'Brien; Deborah Thomas; Gabriela Vidal-Senmache; William G Wierda; Steven M Kornblau; Jorge Cortes
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy.
Cancer 2009;115(11):2482-90.
2009: Ravin Garg; Andrew Lamb; Deborah Thomas; Stefan Faderl; Farhad Ravandi; Denise Lovshe; Sherry Pierce; Susan O'Brien
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.
Cancer 2009;115(10):2147-54.
2009: Jan A Burger; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Guillermo Garcia-Manero; Jorge Cortes; Deborah Thomas; Charles Koller; Jan Burger; Susan Lerner; Andrew Lamb; Michael Keating
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1637-43.
2009: Dushyant Verma; Susan O'Brien; Deborah Thomas; Stefan Faderl; Charles Koller; Sherry Pierce; Partow Kebriaei; Guillermo Garcia-Manero; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
Cancer 2009;115(1):101-6.
2008: Susan O'Brien; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Jorge Cortes; Gautam Borthakur; Sherry Pierce; Guillermo Garcia-Manero; Hagop M Kantarjian
Outcome of adults with acute lymphocytic leukemia after second salvage therapy.
Cancer 2008;113(11):3186-91.
2008: Ahmed Aribi; Andrew Lamb; Charles Koller; Deborah Thomas; Stefan Faderl; Guillermo Garcia-Manero; Jorge Cortes
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Cancer 2008;113(6):1338-43.
2008: Dan Jones; Deborah Thomas; C Cameron Yin; Susan O'Brien; Jorge E Cortes; Elias Jabbour; Megan Breeden; Francis Giles; Weiqiang Zhao; Hagop M Kantarjian
Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors.
Cancer 2008;113(5):985-94.
2008: Arturo Vega-Ruiz; Susan O'Brien; Jorge Cortes; Partow Kebriaei; Deborah Thomas; Andrew Lamb; Farhad Ravandi
Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate.
Leukemia research 2008;32(9):1468-71.
2008: Srdan Verstovsek; Ayalew Tefferi; Jorge Cortes; Susan O'Brien; Guillermo Garcia-Manero; Animesh Pardanani; Cem Akin; Stefan Faderl; Taghi Manshouri; Deborah Thomas; Andrew Lamb
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3906-15.
2007: Luis Fayad; Deborah Thomas; Jorge Romaguera
Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Clinical lymphoma & myeloma 2007;8 Suppl 2():S57-62.
2007: Elias Jabbour; Andrew Lamb; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Alessandra Ferrajoli; Stefan Faderl; Mary Ann Richie; Miloslav Beran; Francis Giles; Srdan Verstovsek
PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study.
Cancer 2007;110(9):2012-8.
2007: Jorge Cortes; Alfonso Quintás-Cardama; Guillermo Garcia-Manero; Susan O'Brien; Dan Jones; Stefan Faderl; Theresa Ebarb; Francis Giles; Deborah Thomas; Andrew Lamb
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure.
Cancer 2007;110(9):2000-6.
2007: Ahmed Aribi; Carlos E Bueso-Ramos; Elihu Estey; Zeev Estrov; Susan O'Brien; Francis Giles; Stefan Faderl; Deborah Thomas; Partow Kebriaei; Guillermo Garcia-Manero; Sherry Pierce; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Biphenotypic acute leukaemia: a case series.
British journal of haematology 2007;138(2):213-6.
2007: William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Andrew Lamb; Michael Keating
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
Blood 2007;109(11):4679-85.
2007: Alfonso Quintás-Cardama; Andrew Lamb; Guillermo Garcia-Manero; Susan O'Brien; Stefan Faderl; Farhad Ravandi; Francis Giles; Deborah Thomas; William G Wierda; Jorge Cortes
A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phase.
Leukemia & lymphoma 2007;48(2):283-9.
2006: Cecilia Arana-Yi; Alfonso Quintás-Cardama; Francis Giles; Deborah Thomas; Antonio Carrasco-Yalan; Jorge Cortes; Andrew Lamb; Srdan Verstovsek
Advances in the therapy of chronic idiopathic myelofibrosis.
The oncologist 2006;11(8):929-43.
2006: Karen W L Yee; Zhihong Zeng; Marina Konopleva; Srdan Verstovsek; Farhad Ravandi; Alessandra Ferrajoli; Deborah Thomas; William G Wierda; Efrosyni Apostolidou; Maher Albitar; Susan O'Brien; Michael Andreeff; Francis Giles
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5165-73.
2006: Francis Giles; Srdan Verstovsek; Guillermo Garcia-Manero; Deborah Thomas; Farhad Ravandi; William G Wierda; Alessandra Ferrajoli; Steven M Kornblau; Elias Jabbour; Jianqin Shan; Susan O'Brien; Maher Albitar; Andrew Lamb
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse.
British journal of haematology 2006;134(1):58-60.
2006: Karen W L Yee; Jorge Cortes; Alessandra Ferrajoli; Guillermo Garcia-Manero; Srdan Verstovsek; William G Wierda; Deborah Thomas; Stefan Faderl; Ivan King; Susan M O'Brien; Sima Jeha; Michael Andreeff; Ann Cahill; Mario Sznol; Francis Giles
Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome.
Leukemia research 2006;30(7):813-22.
2006: Yasuhiro Oki; Hagop M Kantarjian; Xian Zhou; Jorge Cortes; Stefan Faderl; Srdan Verstovsek; Susan O'Brien; Charles Koller; Miloslav Beran; B Nebiyou Bekele; Sherry Pierce; Deborah Thomas; Farhad Ravandi; William G Wierda; Francis Giles; Alessandra Ferrajoli; Elias Jabbour; Michael J Keating; Carlos E Bueso-Ramos; Elihu Estey; Guillermo Garcia-Manero
Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.
Blood 2006;107(3):880-4.
2006: William G Wierda; Susan O'Brien; Stefan Faderl; Alessandra Ferrajoli; Xuemei Wang; Kim-Anh Do; Guillermo Garcia-Manero; Deborah Thomas; Jorge Cortes; Farhad Ravandi-Kashani; Francis Giles; Susan Lerner; Andrew Lamb; Michael Keating
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens.
Cancer 2006;106(2):337-45.
2005: Varsha Gandhi; J Michael Kilpatrick; William Plunkett; Mary Ayres; Leigh Harman; Min Du; Shanta Bantia; Jan Davisson; William G Wierda; Stefan Faderl; Andrew Lamb; Deborah Thomas
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).
Blood 2005;106(13):4253-60.
2005: Farhad Ravandi; Susan O'Brien; Dan Jones; Susan Lerner; Stefan Faderl; Alessandra Ferrajoli; William G Wierda; Guillermo Garcia-Manero; Deborah Thomas; Charles Koller; Srdan Verstovsek; Francis Giles; Jorge Cortes; Marco Herling; Andrew Lamb; Michael Keating
T-cell prolymphocytic leukemia: a single-institution experience.
Clinical lymphoma & myeloma 2005;6(3):234-9.
2005: Francis Giles; Srdan Verstovsek; Deborah Thomas; Stanton Gerson; Jorge Cortes; Stefan Faderl; Alessandra Ferrajoli; Farhad Ravandi; Steven M Kornblau; Guillermo Garcia-Manero; Elias Jabbour; Susan O'Brien; Verena Karsten; Ann Cahill; Karen Yee; Maher Albitar; Mario Sznol; Andrew Lamb
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7817-24.
2005: Karen W L Yee; Anne Hagey; Srdan Verstovsek; Jorge Cortes; Guillermo Garcia-Manero; Susan M O'Brien; Stefan Faderl; Deborah Thomas; William G Wierda; Steven M Kornblau; Alessandra Ferrajoli; Maher Albitar; Evelyn McKeegan; David R Grimm; Toby Mueller; Rhonda R Holley-Shanks; Leonardo Sahelijo; Gary B Gordon; Hagop M Kantarjian; Francis Giles
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6615-24.
2005: Michael J Keating; Susan O'Brien; Maher Albitar; Susan Lerner; William Plunkett; Francis Giles; Michael Andreeff; Jorge Cortes; Stefan Faderl; Deborah Thomas; Charles Koller; William G Wierda; Michelle A Detry; Alice Lynn; Andrew Lamb
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4079-88.
2005: William G Wierda; Susan O'Brien; Sijin Wen; Stefan Faderl; Guillermo Garcia-Manero; Deborah Thomas; Kim-Anh Do; Jorge Cortes; Charles Koller; Miloslav Beran; Alessandra Ferrajoli; Francis Giles; Susan Lerner; Maher Albitar; Andrew Lamb; Michael Keating
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4070-8.
2005: Francis Giles; Hagop M Kantarjian; Jorge E Cortes; Stefan Faderl; Srdan Verstovsek; Deborah Thomas; Guillermo Garcia-Manero; William G Wierda; Alessandra Ferrajoli; Steven M Kornblau; Gloria N Mattiuzzi; Apostolia-Maria Tsimberidou; Maher Albitar; Susan M O'Brien; Elihu Estey
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Leukemia research 2005;29(6):649-52.
2005: Jorge Cortes; Stefan Faderl; Elihu Estey; Razelle Kurzrock; Deborah Thomas; Miloslav Beran; Guillermo Garcia-Manero; Alessandra Ferrajoli; Francis Giles; Charles Koller; Susan O'Brien; John Wright; Stephen A Bai; Andrew Lamb
Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2805-12.
2004: Andrew Lamb; Deborah Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Sima Jeha; Carlos E Bueso-Ramos; Sherry Pierce; Jianqin Shan; Charles Koller; Miloslav Beran; Michael Keating; Emil J Freireich
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Cancer 2004;101(12):2788-801.
2004: Hagop M Kantarjian; Jorge E Cortes; Susan O'Brien; Rajyalakshmi Luthra; Francis Giles; Srdan Verstovsek; Stefan Faderl; Deborah Thomas; Guillermo Garcia-Manero; Mary Beth Rios; Jianqin Shan; Dan Jones; Moshe Talpaz
Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha.
Blood 2004;104(7):1979-88.
2004: Jorge Cortes; Deborah Thomas; Charles Koller; Francis Giles; Elihu Estey; Stefan Faderl; Guillermo Garcia-Manero; David J McConkey; Stacey Ruiz; Gira Patel; Roberto Guerciolini; John Wright; Andrew Lamb
Phase I study of bortezomib in refractory or relapsed acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3371-6.
2004: Francis Giles; Deborah Thomas; Guillermo Garcia-Manero; Stefan Faderl; Jorge Cortes; Srdan Verstovsek; Alessandra Ferrajoli; Sima Jeha; Miloslav Beran; Charles Koller; Michael Andreeff; Ann Cahill; Caroline Clairmont; Mario Sznol; Andrew Lamb
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2908-17.
2004: Andrew Lamb; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Francis Giles; Mary Beth Rios; Jianqin Shan; Laurie Letvak; Deborah Thomas; Stefan Faderl; Alessandra Ferrajoli; Jorge Cortes
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.
Blood 2004;103(8):2873-8.
2004: Jean-Pierre J Issa; Guillermo Garcia-Manero; Francis Giles; Rajan Mannari; Deborah Thomas; Stefan Faderl; Emel Bayar; John Lyons; Craig S Rosenfeld; Jorge Cortes; Hagop M Kantarjian
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Blood 2004;103(5):1635-40.
2004: Gloria N Mattiuzzi; Andrew Lamb; Stefan Faderl; JoAnn Lim; Dimitrios P Kontoyiannis; Deborah Thomas; William G Wierda; Issam Raad; Guillermo Garcia-Manero; Xian Zhou; Alessandra Ferrajoli; Nebiyou Bekele; Elihu Estey
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
Cancer 2004;100(3):581-9.
2003: Apostolia-Maria Tsimberidou; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Srdan Verstovsek; Stefan Faderl; Maher Albitar; Andrew Lamb; Elihu Estey; Francis Giles
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 2003;27(10):893-7.
2003: Susan O'Brien; Francis Giles; Moshe Talpaz; Jorge Cortes; Mary Beth Rios; Jianqin Shan; Deborah Thomas; Michael Andreeff; Steven M Kornblau; Stefan Faderl; Guillermo Garcia-Manero; Kevin White; Susie Mallard; Emil J Freireich; Hagop M Kantarjian
Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
Cancer 2003;98(5):888-93.
2003: Francis Giles; Gary Guangping Shi; Jorge E Cortes; Deborah Thomas; Anna R Keating; Hagop M Kantarjian; Michael J Keating; Susan M O'Brien
Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia.
Cancer chemotherapy and pharmacology 2003;52(3):223-8.
2003: Andrew Lamb; Susan O'Brien; Jorge Cortes; Francis Giles; Deborah Thomas; Steven M Kornblau; Jianquin Shan; Mary Beth Rios; Michael Keating; Emil J Freireich; Moshe Talpaz
Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
Cancer 2003;98(1):81-5.
2003: Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Guillermo Garcia-Manero; Mary Beth Rios; Stefan Faderl; Srdan Verstovsek; Alessandra Ferrajoli; Emil J Freireich; Moshe Talpaz; Andrew Lamb
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha.
Blood 2003;102(1):83-6.
2003: Guillermo Garcia-Manero; Moshe Talpaz; Francis Giles; Jorge Cortes; Stefan Faderl; Susan O'Brien; Deborah Thomas; Srdan Verstovsek; Mary Beth Rios; Jianquin Shan; Alessandra Ferrajoli; William G Wierda; Hagop M Kantarjian
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.
Cancer 2003;97(12):3010-6.
2003: Jorge Cortes; Patricia Ault; Charles Koller; Deborah Thomas; Alessandra Ferrajoli; William G Wierda; Mary Beth Rios; Laurie Letvak; Elizabeth S Kaled; Andrew Lamb
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.
Blood 2003;101(12):4714-6.
2003: Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Maher Albitar; Mary Beth Rios; Moshe Talpaz; Guillermo Garcia-Manero; Stefan Faderl; Laurie Letvak; August Salvado; Andrew Lamb
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cancer 2003;97(11):2760-6.
2003: Guillermo Lazo; Andrew Lamb; Elihu Estey; Deborah Thomas; Susan O'Brien; Jorge Cortes
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
Cancer 2003;97(9):2218-24.
2003: Efrosyni Apostolidou; Elihu Estey; Jorge Cortes; Guillermo Garcia-Manero; Stefan Faderl; Deborah Thomas; Apostolia-Maria Tsimberidou; Andrew Lamb; Francis Giles
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia.
Leukemia research 2003;27(4):301-4.
2003: Taghi Manshouri; Kim-Anh Do; Xuemei Wang; Francis Giles; Susan M O'Brien; Helene Saffer; Deborah Thomas; Iman Jilani; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.
Blood 2003;101(7):2507-13.
2003: Apostolia-Maria Tsimberidou; Elihu Estey; Jorge Cortes; Deborah Thomas; Stefan Faderl; Srdan Verstovsek; Guillermo Garcia-Manero; Michael Keating; Maher Albitar; Susan O'Brien; Andrew Lamb; Francis Giles
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Cancer 2003;97(6):1481-7.
2003: Jorge Cortes; Andrew Lamb; Maher Albitar; Deborah Thomas; Stefan Faderl; Charles Koller; Guillermo Garcia-Manero; Francis Giles; Michael Andreeff; Susan O'Brien; Michael Keating; Elihu Estey
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
Cancer 2003;97(5):1234-41.
2003: Jorge Cortes; Maher Albitar; Deborah Thomas; Francis Giles; Razelle Kurzrock; Alain Thibault; Wayne Rackoff; Charles Koller; Susan O'Brien; Guillermo Garcia-Manero; Moshe Talpaz; Andrew Lamb
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
Blood 2003;101(5):1692-7.
2003: William G Wierda; Marcella M Johnson; Kim-Anh Do; Taghi Manshouri; Amanda Dey; Susan O'Brien; Francis Giles; Andrew Lamb; Deborah Thomas; Stefan Faderl; Susan Lerner; Michael Keating; Maher Albitar
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia.
British journal of haematology 2003;120(3):452-6.
2003: Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Francis Giles; Guillermo Garcia-Manero; Stefan Faderl; Deborah Thomas; Jianqin Shan; Mary Beth Rios; Jorge Cortes
Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia.
Blood 2003;101(2):473-5.
2003: Iman Jilani; Elihu Estey; T Manshuri; M Caligiuri; Michael Keating; Francis Giles; Deborah Thomas; Andrew Lamb; Maher Albitar
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Leukemia 2003;17(1):114-9.
2003: Yesid Alvarado; Apostolia-Maria Tsimberidou; Andrew Lamb; Jorge Cortes; Guillermo Garcia-Manero; Stefan Faderl; Deborah Thomas; Elihu Estey; Francis Giles
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia.
Cancer chemotherapy and pharmacology 2003;51(1):87-90.
2003: Yesid Alvarado; Jorge Cortes; Srdan Verstovsek; Deborah Thomas; Stefan Faderl; Zeev Estrov; Andrew Lamb; Francis Giles
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Cancer chemotherapy and pharmacology 2003;51(1):81-6.
2003: Hagop M Kantarjian; Jorge E Cortes; Susan O'Brien; Francis Giles; Guillermo Garcia-Manero; Stefan Faderl; Deborah Thomas; Sima Jeha; Mary Beth Rios; Laurie Letvak; Kathy Bochinski; Ralph B Arlinghaus; Moshe Talpaz
Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses.
Blood 2003;101(1):97-100.
2002: Jorge Cortes; Apostolia-Maria Tsimberidou; Ricardo Alvarez; Deborah Thomas; Miloslav Beran; Andrew Lamb; Elihu Estey; Francis Giles
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia.
Cancer chemotherapy and pharmacology 2002;50(6):497-500.
2002: Iman Jilani; Elihu Estey; Yang Huh; Youngson Joe; Taghi Manshouri; Marwan Yared; Francis Giles; Andrew Lamb; Jorge Cortes; Deborah Thomas; Michael Keating; Emil J Freireich; Maher Albitar
Differences in CD33 intensity between various myeloid neoplasms.
American journal of clinical pathology 2002;118(4):560-6.
2002: Apostolia-Maria Tsimberidou; Deborah Thomas; Susan O'Brien; Michael Andreeff; Razelle Kurzrock; Michael Keating; Maher Albitar; Andrew Lamb; Francis Giles
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.
Cancer chemotherapy and pharmacology 2002;50(3):237-42.
2002: Guillermo Garcia-Manero; Stefan Faderl; Francis Giles; Deborah Thomas; Jorge Cortes; Susan O'Brien; Jan Davis; Hagop M Kantarjian; Elihu Estey
A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes.
Haematologica 2002;87(8):804-7.
2002: Susan O'Brien; Moshe Talpaz; Jorge Cortes; Jianqin Shan; Francis Giles; Stefan Faderl; Deborah Thomas; Guillermo Garcia-Manero; Susie Mallard; Mary Beth; Charles Koller; Steven M Kornblau; Michael Andreeff; Anthony J Murgo; Michael Keating; Hagop M Kantarjian
Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
Cancer 2002;94(7):2024-32.
2002: Jorge Cortes; Deborah Thomas; Adan Rios; Charles Koller; Susan O'Brien; Sima Jeha; Stefan Faderl; Andrew Lamb
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.
Cancer 2002;94(5):1492-9.
2002: Usha R Surapaneni; Jorge E Cortes; Deborah Thomas; Susan O'Brien; Francis Giles; Charles Koller; Stefan Faderl; Andrew Lamb
Central nervous system relapse in adults with acute lymphoblastic leukemia.
Cancer 2002;94(3):773-9.
2001: Jorge Cortes; Susan O'Brien; J Loscertales; Andrew Lamb; Francis Giles; Deborah Thomas; Charles Koller; Michael Keating
Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cancer 2001;92(8):2016-22.
2001: Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller; Miloslav Beran; Deborah Thomas; Michael Keating; Andrew Lamb
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
Cancer 2001;92(1):7-14.
2001: Farhad Ravandi; Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Stefan Faderl; Francis Giles; Deborah Thomas; Jorge Cortes; Michael Andreeff; Zeev Estrov; Mary Beth Rios; Maher Albitar
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
Cancer 2001;91(11):1964-72.
2000: Alvaro Aguayo; Andrew Lamb; Taghi Manshouri; Christy Gidel; Elihu Estey; Deborah Thomas; Charles Koller; Zeev Estrov; Susan O'Brien; Michael Keating; Emil J Freireich; Maher Albitar
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Blood 2000;96(6):2240-5.
1999: Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Andrew Lamb
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
Cancer 1999;86(7):1203-9.
1999: Stefan Faderl; Zeev Estrov; Hagop M Kantarjian; Deborah Thomas; Jorge Cortes; Taghi Manshouri; C C Chan; K J Hays; Sherry Pierce; Maher Albitar
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
Cytokines, cellular & molecular therapy 1999;5(3):159-63.
1999: Stefan Faderl; Hagop M Kantarjian; Taghi Manshouri; C Y Chan; Sherry Pierce; K J Hays; Jorge Cortes; Deborah Thomas; Zeev Estrov; Maher Albitar
The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1855-61.
1999: B S Dabaja; Stefan Faderl; Deborah Thomas; Jorge Cortes; Susan O'Brien; F Nasr; Sherry Pierce; Kimberly Hayes; Armand B. Glassman; Michael Keating; Hagop M Kantarjian
Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications.
Leukemia 1999;13(6):869-72.
1997: Charles Koller; Hagop M Kantarjian; Deborah Thomas; Susan O'Brien; Mary Beth Rios; Steven M Kornblau; S Murphy; Michael Keating
The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.
Leukemia 1997;11(12):2039-44.